How to Self-Inject Semaglutide Safely at Home

What the clinical evidence tells us about injection-route outcomes

The STEP 1 trial, published in the New England Journal of Medicine, followed 1,961 adults with obesity over 68 weeks. Participants using the once-weekly 2.4 mg subcutaneous injection alongside lifestyle changes lost an average of around 15% of body weight, results achieved through consistent weekly self-injection at home, not clinic visits. That matters here because the evidence base for semaglutide is built entirely on subcutaneous self-injection, and if you want a thorough walkthrough of the practicalities before you begin, the guide to self-injecting semaglutide covers every stage of the process in detail.

NICE recommends semaglutide for eligible adults within a structured weight management programme, and the NICE technology appraisal TA875 underlines that the medicine is used alongside reduced-calorie eating and increased activity. The injection itself is one part of a wider clinical plan, which is why your prescriber's instructions always take precedence over any general technique guide, including this one.

For a fuller picture of how semaglutide works and what to expect across the dose schedule, the Wegovy treatment overview covers the evidence in one place.

Step-by-step: what good injection technique actually looks like

Preparation takes longer than the injection itself. Wash your hands thoroughly. Take the pen out of the fridge roughly 30 minutes before injecting, a slightly warmer pen is more comfortable. Check the pen window: the liquid should be clear or faintly coloured and free of particles. Attach a new needle, prime if your leaflet instructs it for a new pen, then dial to your prescribed dose.

Choose your injection site and clean a small area with an alcohol swab; sterile alcohol swabs work well for this step and are straightforward to keep with your pen. Let the skin dry for a few seconds. Pinch the skin gently, insert the needle at a 90-degree angle (or 45 degrees if you are very lean), press the dose button firmly, and hold for a slow count of ten before withdrawing. That pause matters, it allows the full dose to deliver.

Remove the needle immediately after injection and dispose of it in a sealed sharps bin, which is the legally correct and safe way to handle used needles in the UK. Replace the pen cap and return it to the fridge. A question our prescribers hear most weeks is whether it matters exactly where in the abdomen you inject. The answer is yes, in a small way: keeping injections at least 5 cm from the navel and rotating the exact spot each week noticeably reduces local skin changes over months of treatment.

More detailed visual guidance on the whole process is available on the how to inject semaglutide page.

The sites, the rotation and what happens if the pen gets warm

Three body areas are licensed injection sites: the abdomen, the front of the thigh, and the outer upper arm. The abdomen tends to be the most convenient for self-injection because it is accessible and pinching is easy. Thigh injections work well for people who are very active, since absorption from muscle-adjacent tissue can be marginally faster after exercise. Upper arm sites are harder to reach solo, most people prefer to use this site only when someone can assist.

Within each area, move the precise spot by at least a centimetre each week. A simple pattern (working in a clockwise circle around the abdomen, for example) prevents the small fatty lumps (lipohypertrophy) that build up when the same spot is used repeatedly. Those lumps are not dangerous but they do reduce absorption, which is a practical reason to rotate even when the current site feels comfortable.

Temperature is something many people underestimate. Wegovy pens must be refrigerated, but they have a limited window during which they can be kept at room temperature. If your pen has been left out, the guide to Wegovy storage and temperature explains exactly what to check and when to contact your prescriber rather than inject a potentially affected pen.

If you are new to injections generally, the semaglutide injection explainer covers the needle design and pen mechanics in plain terms.

Side effects at the injection site and when to get medical help

Local reactions (redness, slight bruising, a small raised area) are common and usually settle within a day or two. They are less frequent when technique is consistent: a clean site, the right angle, a full ten-second hold. Persistent lumps or hardened patches at the same spot are a signal to rotate more deliberately.

Systemic side effects from semaglutide are mostly gastrointestinal. Nausea is the most reported; it typically peaks in the days after starting or after a dose increase, then fades as the body adjusts. Constipation, loose stools, reflux and fatigue are also described in the trial data. These are not caused by injection technique; they are pharmacological effects of the medicine itself, generally mild to moderate and temporary.

Seek medical attention promptly for severe stomach pain that extends to the back, with or without vomiting, the MHRA issued a specific safety communication in January 2026 highlighting acute pancreatitis as a known but uncommon risk with GLP-1 medicines, and that symptom pattern is the key warning sign. Allergic reactions (rash, facial swelling, difficulty breathing) also require urgent assessment.

You can report any suspected side effect directly to the MHRA via the Yellow Card scheme. If you are unsure whether what you are experiencing is expected or warrants medical review, contact your prescriber rather than waiting. The weight-loss injections guide covers the broader side-effect profile across GLP-1 medicines, and the nume FAQs address common questions about managing treatment at home.

If you have not yet started treatment and are considering whether Wegovy is right for you, the free eligibility consultation connects you with a GPhC-registered prescriber who reviews your case the same day, no algorithms involved.